Contact
searchSearch
HMP Global

Acne Topic Center

Featured

Acne
News
Acne Vulgaris Associated With Gastrointestinal Issues
12/16/2024
Riya Gandhi, MA
A large-scale study uncovers a significant association between acne vulgaris and gastrointestinal comorbidities, highlighting the importance of a multidisciplinary approach to patient care.
A large-scale study uncovers a significant association between acne vulgaris and gastrointestinal comorbidities, highlighting the importance of a multidisciplinary approach to patient care.
A large-scale study uncovers a...
12/16/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
acne
News
Therapeutic Relevance of Sebum in the Pathophysiology of Acne Vulgaris
09/19/2024
Jessica Garlewicz
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in...
09/19/2024
The Dermatologist
acne
News
Targeted Precision Cryotherapy Treatment for Acne Lesions
09/11/2024
Jessica Garlewicz
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial...
09/11/2024
The Dermatologist
acne
News
Whey Protein Supplementation and Male Acne
08/21/2024
Jessica Garlewicz
Researchers aimed to investigate whether whey protein consumption impacts acne severity in men with mild to moderate facial and/or truncal acne.
Researchers aimed to investigate whether whey protein consumption impacts acne severity in men with mild to moderate facial and/or truncal acne.
Researchers aimed to investigate...
08/21/2024
The Dermatologist
acne
News
Evidence-Based Recommendations for Acne Management
08/09/2024
Jessica Garlewicz
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a...
08/09/2024
The Dermatologist
acne
News
Evolution of Acne Research Based on Top-Cited Articles
05/29/2024
Jessica Garlewicz
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a...
05/29/2024
The Dermatologist
acne
News
The Relationship Between Acne Vulgaris and Metabolic Syndrome
05/13/2024
Jessica Garlewicz
Could the mechanistic Target of Rapamycin have a potential role in explaining the relationship between acne vulgaris and metabolic syndrome in acne pathogenesis?
Could the mechanistic Target of Rapamycin have a potential role in explaining the relationship between acne vulgaris and metabolic syndrome in acne pathogenesis?
Could the mechanistic Target of...
05/13/2024
The Dermatologist
acne
News
Acne’s Impact on Life-Changing Decisions Among Young Adults
05/06/2024
Jessica Garlewicz
Researchers aimed to evaluate the influence of acne on major life-changing decisions in young adults.
Researchers aimed to evaluate the influence of acne on major life-changing decisions in young adults.
Researchers aimed to evaluate...
05/06/2024
The Dermatologist
acne
News
Sequential Multimodal Laser Therapy Improves Acne Scar Geometrics and Texture
04/11/2024
Jessica Garlewicz
Researchers aimed to investigate the efficacy of sequential multimodal laser therapy in improving the geometrics and texture of acne scars.
Researchers aimed to investigate the efficacy of sequential multimodal laser therapy in improving the geometrics and texture of acne scars.
Researchers aimed to investigate...
04/11/2024
The Dermatologist
acne
News
Application of the CenterNet Network for Acne Detection
04/11/2024
Jessica Garlewicz
Researchers aimed to enhance acne detection by assessing image quality, accurately segmenting lesions, and precisely grading acne types.
Researchers aimed to enhance acne detection by assessing image quality, accurately segmenting lesions, and precisely grading acne types.
Researchers aimed to enhance...
04/11/2024
The Dermatologist

Quizzes

Quiz
Trivia: Acne and Depressive Symptoms
02/07/2021
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental...
02/07/2021
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist
Quiz
Air Pollution and Atopic Disease: Evaluating Epidemiologic Evidence
02/26/2026
Riya Gandhi, MA
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the epidemiologic data examining environmental exposures and their association with atopic disease development. This quiz explores key population-level observations shaping modern allergy research.
Test your knowledge of the...
02/26/2026
The Dermatologist
Quiz
Clinical Trial Evaluation of Eyebrow and Eyelash Regrowth in AA
02/05/2026
Riya Gandhi, MA
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how clinical trials assess and define success in eyebrow and eyelash regrowth for patients with alopecia areata.
Test your understanding of how...
02/05/2026
The Dermatologist

Cases

Case Report and Brief Review
What Explains This Recurrent Rash?
09/25/2017
David L. Kaplan, MD
This 51-year-old woman presented with a 2-year history of chronic hand eczema that would partially respond to topical corticosteroids, only to recur. She denied any new exposure history. She had not had the condition in the past. What...
This 51-year-old woman presented with a 2-year history of chronic hand eczema that would partially respond to topical corticosteroids, only to recur. She denied any new exposure history. She had not had the condition in the past. What...
This 51-year-old woman presented...
09/25/2017
The Dermatologist
Case Report and Brief Review
What are These Nodules With Crusts on A Farmer`s cheek?
09/04/2008
Patient Presentation This 48-year-old dairy farmer presented with a 3-month history of boggy, suppurative papules and nodules with crusts on his right cheek. He had been using over-the-counter topical antibiotics, antifungals and topical...
Patient Presentation This 48-year-old dairy farmer presented with a 3-month history of boggy, suppurative papules and nodules with crusts on his right cheek. He had been using over-the-counter topical antibiotics, antifungals and topical...
Patient Presentation This...
09/04/2008
The Dermatologist

From the Issue

Feature Story
Dermatologists Rise to the Challenge of Telemedicine During the Pandemic
10/16/2020
Farhaad Riyaz, MD, FAAD; Dennis Porto, MD, FAAD
Without exception, dermatologists love to guide our patients toward clear skin. As the experts on acne, we know the long-lasting physical and psychological effects that acne and its resultant scars can have on our...
Without exception, dermatologists love to guide our patients toward clear skin. As the experts on acne, we know the long-lasting physical and psychological effects that acne and its resultant scars can have on our...
...
10/16/2020
The Dermatologist
Feature Story
The Role of the Microbiome in Acne
03/12/2020
Yang Yu, MD
In medicine, we have long recognized that the microbial communities in our bodies and on our skin are intricately linked to health and disease. Acne vulgaris is a disease that exemplifies the importance of host-microbiome interactions in...
In medicine, we have long recognized that the microbial communities in our bodies and on our skin are intricately linked to health and disease. Acne vulgaris is a disease that exemplifies the importance of host-microbiome interactions in...
In medicine, we have long...
03/12/2020
The Dermatologist
Feature Story
Searching for Answers: Using YouTube to Learn About Isotretinoin Therapy for Acne
01/16/2020
Amit Om, MD
Patients are searching on YouTube for health care information at an increasing rate. Unfortunately, the majority of uploaded videos are not by health care professionals, which may lead to misinformation about isotretinoin for the treatment of...
Patients are searching on YouTube for health care information at an increasing rate. Unfortunately, the majority of uploaded videos are not by health care professionals, which may lead to misinformation about isotretinoin for the treatment of...
Patients are searching on...
01/16/2020
The Dermatologist
Feature Story
New Developments in the Treatment of Acne Vulgaris
11/12/2019
Leon Kircik, MD
Several new drugs, including oral and topical antibiotics, for the treatment of acne vulgaris are on the horizon that hold the potential to improve patient outcomes.
Several new drugs, including oral and topical antibiotics, for the treatment of acne vulgaris are on the horizon that hold the potential to improve patient outcomes.
Several new drugs, including...
11/12/2019
The Dermatologist
Cover Story
More Than Cosmetic: Reframing Hyperpigmentation as a Clinical and Psychosocial Priority
03/09/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Coleen Stern, MA; Riya Gandhi, MA
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the clinical, psychosocial, and equity-driven imperatives reshaping how dermatologists diagnose and treat hyperpigmentation disorders in patients with skin of color.
Dr Oyetewa Asempa explores the...
03/09/2026
The Dermatologist
Feature Story
Biosimilars in Dermatology: What Clinicians Need to Know in 2026
03/09/2026
Omar Raheel, BA; Jade Bajic, BSc; Ryan Hirsh, BS; Steven R. Feldman, MD, PhD
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions about biosimilars, including what they are, how they are regulated, and how they affect prescribing, insurance coverage, and patient care.
Get the answers to key questions...
03/09/2026
The Dermatologist
Feature Story
Beyond the Gut: Recognizing and Managing Inflammatory Bowel Disease in Dermatologic Practice
03/09/2026
David Fudman, MD; Riya Gandhi, MA
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David Fudman examines our evolving understanding of the gut-skin axis and the pivotal role dermatologists play in identifying and comanaging the cutaneous symptoms of luminal disease.
Gastroenterologist Dr David...
03/09/2026
The Dermatologist
HSF-Reviewed Content
From Reactive to Proactive: Building Longitudinal Care Plans That Actually Work for Hidradenitis Suppurativa
03/09/2026
Mondana Ghias, MD, FAAD
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach,...
03/09/2026
The Dermatologist
Cover Story
Forward Focus: Top Trends in Dermatology for 2026
01/30/2026
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and...
01/30/2026
The Dermatologist
Cover Story
Redefining the Standard: Adjuvant and Neoadjuvant Immunotherapy in High-Risk, Advanced CSCC
12/09/2025
Vishal A Patel, MD
With new data supporting adjuvant cemiplimab and promising outcomes from neoadjuvant strategies, immunotherapy is reshaping the treatment landscape for high-risk and advanced cutaneous squamous cell carcinoma.
With new data supporting adjuvant cemiplimab and promising outcomes from neoadjuvant strategies, immunotherapy is reshaping the treatment landscape for high-risk and advanced cutaneous squamous cell carcinoma.
With new data supporting...
12/09/2025
The Dermatologist
Cover Story
Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella
10/06/2025
Jeff Yu, MD
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more...
10/06/2025
The Dermatologist
Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist
MASTERCLASSES IN DERMATOLOGY FORUM
Redefining Remission and Low Disease Activity in Dermatology
10/06/2025
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an abstract dream; it is the evolving standard we must pursue with clarity, creativity, and urgency.
Remission is no longer an...
10/06/2025
The Dermatologist
Cover Story
Janus Kinase Inhibitors and Alopecia Areata: From Data to Dialogue
09/08/2025
Justin M. Ko, MD, MBA
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares patient-centered strategies for discussing boxed warnings, risk assessment, and therapeutic goals.
Dr Justin Ko shares...
09/08/2025
The Dermatologist

News

Acne
News
Acne Vulgaris Associated With Gastrointestinal Issues
12/16/2024
Riya Gandhi, MA
A large-scale study uncovers a significant association between acne vulgaris and gastrointestinal comorbidities, highlighting the importance of a multidisciplinary approach to patient care.
A large-scale study uncovers a significant association between acne vulgaris and gastrointestinal comorbidities, highlighting the importance of a multidisciplinary approach to patient care.
A large-scale study uncovers a...
12/16/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
acne
News
Therapeutic Relevance of Sebum in the Pathophysiology of Acne Vulgaris
09/19/2024
Jessica Garlewicz
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in the pathophysiology of acne vulgaris have been long debated.
Sebum production and its role in...
09/19/2024
The Dermatologist
acne
News
Targeted Precision Cryotherapy Treatment for Acne Lesions
09/11/2024
Jessica Garlewicz
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial investigated the feasibility and efficacy of precision cryotherapy as an alternative treatment for acne vulgaris.
This pilot clinical trial...
09/11/2024
The Dermatologist
acne
News
Whey Protein Supplementation and Male Acne
08/21/2024
Jessica Garlewicz
Researchers aimed to investigate whether whey protein consumption impacts acne severity in men with mild to moderate facial and/or truncal acne.
Researchers aimed to investigate whether whey protein consumption impacts acne severity in men with mild to moderate facial and/or truncal acne.
Researchers aimed to investigate...
08/21/2024
The Dermatologist
acne
News
Evidence-Based Recommendations for Acne Management
08/09/2024
Jessica Garlewicz
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a systematic review in order to formulate guidelines for clinicians in effectively managing acne vulgaris.
A work group conducted a...
08/09/2024
The Dermatologist
acne
News
Evolution of Acne Research Based on Top-Cited Articles
05/29/2024
Jessica Garlewicz
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a...
05/29/2024
The Dermatologist
acne
News
The Relationship Between Acne Vulgaris and Metabolic Syndrome
05/13/2024
Jessica Garlewicz
Could the mechanistic Target of Rapamycin have a potential role in explaining the relationship between acne vulgaris and metabolic syndrome in acne pathogenesis?
Could the mechanistic Target of Rapamycin have a potential role in explaining the relationship between acne vulgaris and metabolic syndrome in acne pathogenesis?
Could the mechanistic Target of...
05/13/2024
The Dermatologist
acne
News
Acne’s Impact on Life-Changing Decisions Among Young Adults
05/06/2024
Jessica Garlewicz
Researchers aimed to evaluate the influence of acne on major life-changing decisions in young adults.
Researchers aimed to evaluate the influence of acne on major life-changing decisions in young adults.
Researchers aimed to evaluate...
05/06/2024
The Dermatologist
acne
News
Sequential Multimodal Laser Therapy Improves Acne Scar Geometrics and Texture
04/11/2024
Jessica Garlewicz
Researchers aimed to investigate the efficacy of sequential multimodal laser therapy in improving the geometrics and texture of acne scars.
Researchers aimed to investigate the efficacy of sequential multimodal laser therapy in improving the geometrics and texture of acne scars.
Researchers aimed to investigate...
04/11/2024
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive

More Acne Articles and Interviews

acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
acne
Quiz
Insights: Clascoterone Cream 1%
11/06/2025
Jessica Garlewicz
According to Dr Mark Lebwohl’s Fall Clinical 2025 presentation, which of the following statements about clascoterone cream 1% is correct?
According to Dr Mark Lebwohl’s Fall Clinical 2025 presentation, which of the following statements about clascoterone cream 1% is correct?
According to Dr Mark Lebwohl’s...
11/06/2025
The Dermatologist
acne
Conference Coverage
Optimizing Acne Management With Durable Topical and Oral Therapies
10/28/2025
Jessica Garlewicz
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025 session, Mark Lebwohl, MD, reviewed recent data supporting the long-term efficacy of topical and oral therapies in acne management, focusing on durability, scarring, and sebum reduction.
At the Fall Clinical 2025...
10/28/2025
The Dermatologist
Hilary Baldwin, MD
Conference Coverage
Advances in Topical Acne Treatments: Balancing Efficacy with Patient Safety
10/13/2025
Jessica Garlewicz
During Dermatology Week, Steven Feldman, MD, PhD, was joined by Hilary Baldwin, MD; Ruth Ann Vleugels, MD, MPH, MBA; and Vincent Richer, MD, FRCPC, to discuss advances and considerations in topical acne treatments.
During Dermatology Week, Steven Feldman, MD, PhD, was joined by Hilary Baldwin, MD; Ruth Ann Vleugels, MD, MPH, MBA; and Vincent Richer, MD, FRCPC, to discuss advances and considerations in topical acne treatments.
During Dermatology Week, Steven...
10/13/2025
The Dermatologist
acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use